We provide the cellular starting material and blood products essential for advancing research and therapeutic applications in the academic, biotechnology and pharmaceutical sectors. Our commitment to excellence ensures that you have access to the vital components needed for your work.
Mobilised Leukopaks
Our mobilised peripheral blood stem cells (GCSF-mobilised PBSC) are sourced from healthy human donors. All donors are medically screened to the same level as our transplant donors ensuring researchers and clinicians have access to a reliable solution for patient therapies and clinical trials.
Leukapheresis
- Fresh Leukopaks. Our highly concentrated fresh leukopaks provide an abundant source of leukocytes, ideal for diverse research applications. These are collected from human donors and are processed to maintain their viability and functionality.
- Cryopreserved Leukopaks. For your convenience, we also supply cryopreserved leukopaks. These products are carefully frozen to ensure long-term storage without compromising cellular integrity, making them readily available when you need them.
Isolated cells
We specialise in providing isolated cells, including:
- T cells. Essential for immunotherapy research, our T cell products are purified and available for various experimental needs.
- CD34+ hematopoietic stem-progenitor cells. These cells play a key role in hematopoiesis and are vital for studies in regenerative medicine and cancer treatment.
Umbilical cord and tissue
Umbilical cord and placental blood are rich sources of stem and progenitor cells, applicable in treating various blood cancers, immune deficiencies, and genetic disorders. Umbilical tissue provides mesenchymal stromal cells, known for their ability to self-renew and differentiate into various tissue types, offering potential benefits in numerous conditions.
We provide:
- Fresh collected whole cord blood
- Cryopreserved reduced-volume cord blood
- Fresh Cord Tissue
- Isolated Cells, including CD34+ hematopoietic stem cells and Natural Killer (NK) cells
- Enriched Products, such as mononuclear cells (MNC), platelet-poor plasma (PPP), and platelet-rich plasma (PRP)
The progenitor cells found in cord blood present a unique potential for developing novel cell therapies, making our bank a preferred choice for partners engaged in advanced therapies and regenerative medicine.
Want to know more?
Fill out our contact us form, and we’ll aim to get back to you within one working day to discuss.